[Congressional Record Volume 170, Number 30 (Thursday, February 15, 2024)]
[House]
[Page H680]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

           By Mr. McCAUL:
       H.R. 7384.
       Congress has the power to enact this legislation pursuant 
     to the following:
       Artile I, Section 8
       The single subject of this legislation is:
       This bill reauthorizes a Food and Drug Administration (FDA) 
     program that awards priority review vouchers to manufacturers 
     of drugs that treat rare pediatric diseases.